New research shows that during moments of lost focus after poor sleep, the brain releases a wave of cerebrospinal fluid (CSF)—the same cleansing process that normally occurs during deep sleep.

The Quest AD-Detect® blood-based test panels deliver confirmatory accuracy, potentially supporting reduced reliance on ...

Expands commercial readiness and diagnostic, manufacturing footprintAppoints new leadership in commercial strategy and technical ...

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...

And now, 20 Final Thoughts from college football’s Week 5, when Oregon and Alabama ruined the nights of a combined 200,000 home spectators. 1. It doesn’t seem to matter how much the people who run ...

For decades, diagnosis of brain cancer has been medicine’s most difficult and hazardous challenge. Simple imaging such as MRI scans may reveal a suspicious-looking lesion, but the only sure way to ...

TORONTO — An expert panel convened by the Alzheimer’s Association has released the first clinical guidelines to help clinicians choose the most appropriate blood-based biomarker (BBM) test to aid in ...

Alzheimer's Drug Discovery Foundation calls for guidelines for FDA-approved blood tests to continue momentum toward precision medicine NEW YORK, July 30, 2025 /PRNewswire/ -- Expanding the use of ...